Could deep tech companies bring about an age of abundance? Matt Ocko, co-founder and managing partner of Data Collective Venture Capital, joins Azeem Azhar to explore the art of investing in startups that aim to transform entire industries with radically cheaper, cleaner products. They also discuss: Why establishing “computational advantage” is key to a successful deep tech approach. How AbCellera, one of Matt’s portfolio companies, used machine learning and extensive automation to swiftly develop an antibody therapy for Covid-19. How investors should judge the right time to invest in a new technology. @mattocko @azeem @ExponentialView Further resources: “Materials Built by Microbes: A Revolution in Materials Science” (Exponential View, Podcast 2020) “This College Professor Became An Overnight Billionaire Fighting Covid” (Forbes, 2021) “With fresh support from its billionaire backers Pivot Bio is ushering in a farming revolution” (TechCrunch, 2020) Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
No persons identified in this episode.
This episode hasn't been transcribed yet
Help us prioritize this episode for transcription by upvoting it.
Popular episodes get transcribed faster
Other episodes from Azeem Azhar's Exponential View
Transcribed and ready to explore now
The method of invention, AI's new clock speed and why capital markets are confused
05 Dec 2025
Azeem Azhar's Exponential View
Why the AI productivity gains haven’t arrived - yet
21 Nov 2025
Azeem Azhar's Exponential View
Where did all the entry-level jobs go? (With Revelio CEO Ben Zweig)
14 Nov 2025
Azeem Azhar's Exponential View
The demand for infinite compute
07 Nov 2025
Azeem Azhar's Exponential View
Inside the US–China decoupling: What’s really at stake (AI, rare earths, Taiwan, trade)
23 Oct 2025
Azeem Azhar's Exponential View
Inside the collapse of the internet economy (and what comes next)
08 Oct 2025
Azeem Azhar's Exponential View